When and How to Administer Oxytocin for Active Management of Third Stage of Labour

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To compare the efficacy of the route and timing of oxytocin administration for Active management of third stage of labour (AMTSL).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Etlik Zubeyde Hanim Womens' Health and Teaching Hospital; Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• having a singleton pregnancy above 37th gestational week

• normal live vaginal delivery with cephalic presentation

• being in active labor

Exclusion Criteria:

• Fetal demise

• multiple pregnancy

• known coagulation disorder

• presentation anomalies

• placental pathology

• liver disease

• thrombocytopenia

• hypertension or being currently on anticoagulants

• having a cesarean section, operative delivery or deep vaginal tear

• chorioamnionitis

• developing HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) or DIC (disseminated intravascular coagulation) before delivery